I plan to do this drawing on May 1, so you've got 5 days left to get in on this!

I quilted a wall-hanging to give to a randomly selected donor to our #woMMen 's trek in Peru, fundraising for 4 wonderful myeloma organizations - QRs below:

Dynamic Prognostic Survival Model Incorporating PROs for TIE Patients With MM with Hsien Seow PhD Amaris Balitsky Tanya Wildes MD Alissa Visram. Thank you Leukemia & Lymphoma Society of Canada for funding Canadian research with ICES Myeloma Canada McMaster Research Hamilton Health Sciences ECRI - ESCARPMENT CANCER RESEARCH INSTITUTE…

As many frailty scores as gelato flavours in Turin Italy! RobertoMina_MD EMN

MY13 trial by CCTG Annette Hay Myeloma Canada McMaster Research ECRI - ESCARPMENT CANCER RESEARCH INSTITUTE study highlighted by RobertoMina_MD at EMN

Important work done by Myeloma Canada being highlighted by Charlotte Pawlyn on how to ensure ours trials and research goals align with what patients want EMN

My favourite session about to start-What trials do we need in the future? with these two super stars Charlotte Pawlyn RobertoMina_MD EMN

Fantastic session on AL amyloid EMN by Suzanne Lentzsch, MD, PhD and others, excited to see your trial progress Raj Chakraborty

Looking forward to this session. How can we all work collaboratively with academics, pharma, patients support partners to move the field forward.

Well I have a great mentor ECRI - ESCARPMENT CANCER RESEARCH INSTITUTE McMaster Research Tanya Wildes MD, hopefully we will have follow up data soon on how these categories change over time in the real world.

Now time to build the infrastructure, capacity, and funding for this as standard of care test for MM patients in Canada with Myeloma Canada Canadian Myeloma Research Group

Fascinating discussion so far....

Check out our Young SIOG position paper highlighting some of the #geriheme research presented at #ASH23 !

Thankful for this dream team ✨ of co-authors Drs. O. Akhtar, Mazie Tsang, MD, MAS, MS Hira Mian
Ajay Major, MD, MBA Pallawi Torka!

ASH
Journal of Geriatric Oncology Cancer and Aging Research Group (CARG) #GeriOnc ASCO GeriOncCoP SIOG

Here we go, first patient enrolled in the myeloma MY13 Dara de escalation trial today at Hamilton Health Sciences ECRI - ESCARPMENT CANCER RESEARCH INSTITUTE CCTG Myeloma Canada Annette Hay

📢Join us TODAY!

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

FREE registration
👇👇
bit.ly/4ai0F87

⏲️6pm CET, 12pm NY

Hira Mian Mohamad Mohty

NEW ✨ Hamilton Health Sciences researcher and hematologist Dr. Tobias Berg is passionate about improving outcomes for people diagnosed with acute myeloid leukemia. Find out more about his leading-edge research Centre for Discovery in Cancer Research #research #CancerAwarenessMonth hamiltonhealthsciences.ca/share/acute-my…

Ben Diamond, MD Rahul Banerjee, MD, FACP Raj Chakraborty Beth Faiman PhD Siddharth Kunte, MD Louis Williams Jack Khouri Faiz Anwer MD Joshua Richter, MD, FACP time will tell+ i hope unrelated . I am worried cause 1) no signal for bispecif.+similar patient profile (lot/asct) 2) prolonged cytopenias are cart specific so something is up there 3) 9% mds risk at 3 yrs in RW studies. Early data suggest an immune mechanism not DNA damage

Hamilton Health Sciences researcher Dr. Gregory Pond is the lead statistician and co-investigator for 2 clinical trials that are changing the diagnostic pathway for all people suspected of having prostate cancer. #HHSresearch #CancerAwarenessMonth hamiltonhealthsciences.ca/share/prostate…

NEW TRIAL! Sascha Tuchman UNC Lineberger leads Alliance for Clinical Trials in Oncology A062102-a trial that compares iberdomide maintenance therapy to disease monitoring to improve survival in pts who have received idecabtagene vicleucel for multiple #myeloma : bit.ly/Alliance-A0621… #mmsm Multiple Myeloma Hub #NCI #NCTN